ABSTRACT
Objective: To identify regional brain metabolic dysfunctions associated with Neuropsychiatric Symptoms (NPS) in Preclinical Alzheimer Disease (AD).
Methods: We stratified 115 cognitively normal individuals into preclinical AD (both amyloid and tau pathologies present), asymptomatic at risk for AD (either amyloid or tau pathology present),
The post Neuropsychiatric Symptoms Predict Hypometabolism in preclinical Alzheimer disease appeared first on Palm Beach Neurological Center.
This post first appeared on News & Announcements Archives - Palm Beach Neurolo, please read the originial post: here
